FAQs

Opiate addiction is defined by the American Society of Addiction Medicine as a primary, chronic, neurobiological disease. Its development and manifestations are influenced by genetic, psychosocial, and environmental factors. The condition is characterized by behaviors including impaired control over drug use, compulsive use, continued use despite harm, and cravings.

Yes, opiate addiction is a treatable disease. Scientific advancements in addiction research have led to improved drug abuse treatment methods, helping individuals stop drug abuse and regain control of their lives. Effective treatment addresses the whole person, and like other chronic diseases, addiction can be successfully managed with proper care.

Methadone is primarily utilized in the treatment of opioid dependence. It has cross-tolerance with various opioids, including Oxycontin, Percocet, Lortabs, morphine, and heroin. Oral methadone doses are administered to stabilize patients and prevent withdrawal symptoms. Higher doses can block the euphoric effects of other opiates, enabling patients at therapeutic dose levels to reduce or cease use of short-acting pain medications or heroin.

Methadone treatment is available for adults who are 18 years of age or older. Additionally, individuals must have a documented history of opioid use lasting 12 months or more to be eligible for methadone treatment.

The duration of addiction treatment varies based on an individual's specific problems and needs. Research indicates that most addicted individuals require at least three months of treatment to significantly reduce or stop drug use. Longer treatment durations often lead to better outcomes. It's important to note that recovery from drug addiction is a long-term process, and relapses may occur, signaling a need for treatment adjustment or reinstatement.